Psychedelic Medicine Series: Part I

Microdose invites you to join the Psychedelic Medicine Series. Series dedicated to bringing together practicing clinicians, researchers, and experts to explain and discuss the therapeutic use of psychedelic medicine in practice.

Psychedelic Medicine Series: Part I
Mar 11, 2021, 2:00pm EST

About the Event Series

With psychedelics entering the mainstream, it is imperative that clinicians are brought up to speed and kept up to date to ensure the most responsible use of these medicines in clinical practice. Psychedelic Medicine Series provides high-quality information to the doctors NOW so that by the time the legal framework shifts, clinicians are well informed and ready to be active participants in this emerging frontier of medicine.

Discover the Speakers

Lynn Marie Morski, MD

Psychedelic Medicine Association

Dr. Lynn Marie Morski is the president of the Psychedelic Medicine Association, host of the Plant…

Dr. Pamela Kryskow

Medical Lead Roots To Thrive / Ketamine Assisted Therapy
No company to promote....shocking

Dr. Pamela Kryskow is a medical doctor with a strong interest in chronic pain, mental health and…

Dr. Mark Braunstein, DO, CEO

Founder & CEO
Reconscious Medical

“Dr. B,” is a paradigm-shifting psychiatrist. Shortly after his residency, he began exploring the…

Dr. Hayden Rubensohn


Dr. Hayden Rubensohn completed medical training at the University of Calgary in 2012. He began his…

Dr. Rishi Kakar

Chief Scientific Officer
SegalTrials (

Dr. Kakar is the Chief Scientific Officer for Segal Trials, a neuroscience focused research…

Presenting Sponsor

Mydecine Innovations Group Inc.

Mydecine Innovations Group™ (CSE:MYCO) is a publicly traded life sciences syndicate, with offices in Denver, CO, USA and Vancouver, BC, Canada.

Mydecine is dedicated to the development and production of adaptive pathway medicine and natural health products all stemming from mushrooms. Mydecine’s experienced multi-talented team has the dynamic capabilities to oversee all areas of Schedule I drug development, including but not limited to synthesis, genetic research, delivery mechanism design, clinical trial execution; through to worldwide product commercialization, marketing and spore-to-sale™ distribution of cGMP psilocybin API’s and non-psychedelic medicinal fungi.

By leveraging strategic partnerships with global scientific, medical, clinical, and Veteran organizations; Mydecine is well positioned at the forefront of naturally derived medicine, alternative therapeutics, and fungtional™ mushroom vitality consumer goods. Our portfolio of unified companies, including Mydecine Health Sciences™, Mindleap Health™, and NeuroPharm™ focus together on providing innovative and effective solutions that can help millions of people live a healthier quality life.

Frequently Asked Questions

Recordings will be put on YouTube after the show, typically within 5 business days.

For the full experience, it’s recommended that you use a personal computer running Chrome 79+ or Firefox 76+. Safari will run in lite (non-interactive) mode, meaning you can watch the panels but not interact with the features of the platform.

You’ll get an email the morning of the event with a link to access the platform.

Get Tickets Now

*If you have a coupon code, you can use it during checkout.
**Purchasing a ticket gets you lifetime access to recordings.

Privacy Preference Center